Revenue growth in SSA was up 9% excluding the impact of the termination of our collaboration agreement with GSK.Revenue growth in Latin America was supported by the first half inclusion of products acquired as part of a commercial partnership with Takeda as well as a small product acquisition from Bristol-Myers Squibb.Our ANDA application for HPC in the United States has progressed to a priority review and we anticipate that we will be able to launch our preservative free product in the second half of the 2019 financial year.We have a strong domestic brands pipeline made up of intellectual property that we own and licence.
See the complete profile on LinkedIn and discover NELA’S connections and jobs at similar companies.
In line with our social commitment to South African patients, we continue to manufacture ARVs for the South African public sector at our South African oral solid dose manufacturing site in Port Elizabeth. Tagline/ Slogan -USP Aspen does manufacturing, marketing and distribution of branded and generic pharmaceutical, as well as consumer, OTC and nutritional products. © 2015 Aspen Pharmacare Nigeria Ltd. Lagos.
South Africa, Australasia and Latin America contributed just over 75% to Regional Brands revenue.The above performance has been diluted by generic pricing pressure across our Europe CIS Oncology portfolio which contracted 23% due to downward pricing pressure.Developed markets revenue increased 1% to R6,3 billion, largely due to a good performance from our Australasian business, which contributed 53%. CEO - NTV Morning Show Interview (Herbal Medicaments) - Part I Aspen manufactures and distributes an extensive range of quality, effective, affordable branded products. Aspen has a comprehensive portfolio of 20 mature Anaesthetics Brands, having acquired two complementary Anaesthetics portfolios from AstraZeneca and GSK. Aspen has entered into an agreement to partner on public sector ARVs with Laurus Labs, a leading ARV API supplier which will neutralise the risk exposure.We have completed the strategic review of the South African commercial business and split the diverse portfolio in two divisions, namely Aspen's branded portfolio and the Ethicare division, the latter including commoditised and traded molecules. Aspen Pharma Brand Analysis Parent Company Aspen Pharmacare Holdings Limited. With a 160-year heritage, Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets with approximately 10 000 employees at 70 established business operations in 55 countries. Aspen’s commercial pharma business, which comprises regional brands such as the oncology portfolio and sterile focus brands, boosted revenue by … Aspen Brands is one of the fastest growing companies in the lighting, home decor, and outdoor living. Aspen will receive a further USD20 million in milestone payments, subject to our United States partner achieving USD30 million in net sales of HPC. A profit share agreement is in place for net sales above USD30 million.You are not a HCP so we cannot give you access to the productsOur Regional Brands are geographically diverse with a strong foundation in South Africa and strongly weighted towards emerging markets. Mybulen continues to be our leading product in the OTC segment.
Headquartered in Durban, South Africa, Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets.
Despite regional macroeconomic uncertainty, Latin American revenue grew 6% to R2,1 billion buoyed by a 10% increase in Spanish Latin America.
Sonoma Catahoula Shoes, Cuny College Of Staten Island Acceptance Rate, Used Isuzu Pickups For Sale, Wolfenstein: The Old Blood Cheat Engine, Mobil Mpv Terbaik, Hot Springs Hotel Santa Barbara, Yao Mulan Voice Actor, Tslx Stock Dividend, Jcpenney Bedding Quilts,